Breast surgery
Breast surgery is a medical procedure with 16 clinical trials. Currently 5 active trials ongoing. Historical success rate of 85.7%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
7
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
75.0%
6 of 8 finished
25.0%
2 ended early
5
trials recruiting
16
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Impact of Regional Anesthesia on Chronic Post-operative Pain
Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer
Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer
Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
Clinical Trials (16)
Impact of Regional Anesthesia on Chronic Post-operative Pain
Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer
Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer
Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers
MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer
Microwave Ablation Combined With Camrelizumab in the Treatment of Early Breast Cancer
Prediction of Chronic Postsurgical Pain in Adults
Effect of Suture Material on Postoperative Nipple Areolar Complex Widening
Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer
Factor Influencing Breast Surgery Type Decision-Making
Neoadjuvant Therapy in Clinical Stage I-III HER2-positive Breast Cancer.
Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer
Oncoplastic Breast-conserving Surgery in Non-metastatic Breast Cancer Patients
Prospective Non-randomized Evaluation of Oncoplastic Surgery
All 16 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 16